End Cash: The amount of cash held by the company for the given period.
CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) had End Cash of $8.55M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.08M |
|
$-3.48M |
|
$0.27M |
|
$-0.19M |
|
$3.58M |
|
$-3.51M |
|
$0.02M |
|
$-3.48M |
|
$-3.48M |
|
$-3.48M |
|
$-3.48M |
|
$-3.48M |
|
$-3.48M |
|
$-3.51M |
|
$-3.28M |
|
12.72M |
|
12.72M |
|
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$9.62M |
|
$1.65M |
|
$4.47M |
|
$14.09M |
|
$2.63M |
|
-- |
|
$2.15M |
|
$4.78M |
|
$9.30M |
|
$9.22M |
|
$9.30M |
|
12.78M |
|
| Cash Flow Statement Financials | |
$-6.48M |
|
$-0.01M |
|
$3.10M |
|
$11.91M |
|
|
End Cash |
$8.55M |
$-3.36M |
|
$1.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.66 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-249.35% |
|
-4554.55% |
|
-4554.55% |
|
-- |
|
-4523.38% |
|
-4523.38% |
|
$-6.50M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.50 |
|
0.30 |
|
296.88 |
|
-37.43% |
|
-37.79% |
|
-24.72% |
|
-37.43% |
|
$0.73 |
|
$-0.51 |
|
$-0.51 |
|